Butyrate increases the efficiency of translation of γ-globin mRNA
- 15 February 2005
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 105 (4) , 1807-1809
- https://doi.org/10.1182/blood-2004-02-0454
Abstract
Fetal hemoglobin (Hb F) levels increase in most patients with sickle cell disease following intermittent butyrate therapy. Although the full effects of butyrate on Hb F levels usually require multiple treatment cycles, in some patients a peak level is achieved after a few days of butyrate therapy. Our investigation of the mechanism(s) responsible for this rapid induction of Hb F by butyrate showed that reticulocyte γ-globin chain synthesis markedly increased within 24 hours of butyrate exposure, without concomitant changes in reticulocyte γ-globin mRNA levels. This suggests that butyrate might induce Hb F by increasing the efficiency of translation of γ-globin mRNA. This hypothesis was confirmed by ribosome loading studies that demonstrated enrichment of the polysomal fraction of reticulocytes with γ-globin mRNA following butyrate exposure. Thus, the induction of Hb F by butyrate may be mediated by translational effects in addition to its well-known effects on transcription of the γ-globin genes. (Blood. 2005;105:1807-1809)Keywords
This publication has 40 references indexed in Scilit:
- In Vivo Association of the Stability Control Protein αCP with Actively Translating mRNAsMolecular and Cellular Biology, 2003
- Extended Therapy with Intravenous Arginine Butyrate in Patients with β-HemoglobinopathiesNew England Journal of Medicine, 1995
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Position independence and proper developmental control of gamma-globin gene expression require both a 5' locus control region and a downstream sequence element.Molecular and Cellular Biology, 1994
- A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin DisordersNew England Journal of Medicine, 1993
- Hematologic Responses of Patients with Sickle Cell Disease to Treatment with HydroxyureaNew England Journal of Medicine, 1990
- Delay in the Fetal Globin Switch in Infants of Diabetic MothersNew England Journal of Medicine, 1985
- Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.Journal of Clinical Investigation, 1984
- Augmentation of Fetal-Hemoglobin Production in Anemic Monkeys by HydroxyureaNew England Journal of Medicine, 1984
- Switch from fetal to adult hemoglobin is associated with a change in progenitor cell population.Journal of Clinical Investigation, 1983